tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Kevin Degeeter, 106 are a BUY (93.81%), 6 are a HOLD (5.31%), 1 are a SELL (0.88%).
Analyst Kevin Degeeter, currently employed at LADENBURG, carries an average stock price target met ratio of 49.62% that have a potential upside of 50.05% achieved within 307 days. Previously, Kevin Degeeter worked at OPPENHEIMER.
Kevin Degeeter’s has documented 206 price targets and ratings displayed on 32 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on ANTX, AN2 Therapeutics at 13-Sep-2023.
Analyst best performing recommendations are on DMTK (DERMTECH).
The best stock recommendation documented was for NVTA (INVITAE CORP) at 1/12/2021. The price target of $51 was fulfilled within 1 day with a profit of $3.41 (7.17%) receiving and performance score of 71.65.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy
$11
$9.08 (472.92%)
$10
1 months 21 days ago
(17-Aug-2025)
0/2 (0%)
$7.85 (249.21%)
Buy
$8
$6.08 (316.67%)
4 months 19 days ago
(19-May-2025)
1/2 (50%)
$4.23 (112.20%)
25
Hold
$4
$2.08 (108.33%)
$60
6 months 7 days ago
(01-Apr-2025)
2/5 (40%)
$0.25 (6.67%)
8
Hold
$120
1 years 29 days ago
(09-Sep-2024)
1/3 (33.33%)
$53.4 (80.18%)
69
Buy
$80
2 years 9 months 4 days ago
(05-Jan-2023)
2/3 (66.67%)
$58.3 (268.66%)
204
What Year was the first public recommendation made by Kevin Degeeter?
